KM Research Hub
← 返回论文库
待处理 入排:排除 图源:待检查

NRG-BR008/HERO study: a Phase III randomized trial of radiotherapy optimization for low-risk HER2-positive breast cancer.

Lior Z Braunstein, Melissa P Mitchell, Hanna Bandos, William M Sikov, Atif J Khan, Peter Y Chen, Patricia A Ganz, Reshma Jagsi, Julia R White, Reena S Cecchini, Hyejoo Kang, Shannon L Puhalla, Kelly L Bolton, Eileen P Connolly, Erica M Stringer-Reasor, Kimberly R Gergelis, Thomas B Julian, Eleftherios P Mamounas, Norman Wolmark

Future Oncol 21(16) 2017-2025

PMID40574381
PMCIDPMC12218515
DOI10.1080/14796694.2025.2511586
发表日期2025-06-27
摘要

摘要

NCT05705401 (ClinicalTrials.gov).

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。